Mexico Dimenhydrinate Market, By Prescription Type (Over-the-Counter (OTC) and Prescription Drugs), Application (Nausea, Vomiting, Dizziness, Insomnia, Allergies, and Others), Route of Administration (Oral and Parenteral), Dosage Form (Tablets, Chewables, Syrup, Injections, Others), Product Type (Branded, Generic), Age (Adult, Geriatric, Child), Distribution Channel (Store Based Retail and Online Based Retail), Country (Mexico) Industry Trends and Forecast to 2029
Market Analysis and Insights : Mexico Dimenhydrinate Market
Mexico dimenhydrinate market is expected to gain significant growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyzes that the market is growing with a CAGR of 2.4% in the forecast period of 2022 to 2029 and is expected to reach USD 1,054.36 thousand by 2029. Rising incidences of motion sickness and allergies are expected to drive the growth of the Mexico dimenhydrinate market.
Dimenhydrinate is an antihistamine that is used to circumvent and cure dizziness, nausea, and vomiting caused by motion sickness in children and adults. Dimenhydrinate belongs to a group of medications called antihistamines. It works by preventing problems with body balance. Dimenhydrinate is an antihistamine that reduces the natural chemical histamine in the body. The first dose should be taken 30 minutes to one hour before traveling or beginning any activity to avoid motion sickness. The dimenhydrinate is marketed as dramamine, draminate and gravol. These trade forms of dimenhydrinate are used as over-the-counter medication. Sometimes, dimenhydrinate is also used to cure Meniere's disease (a condition in the inner ear that causes extreme dizziness, loss of balance, and loss of hearing) and other inner ear problems.
The rising prevalence of nausea, vomiting, and allergies among the Mexican population may drive the Mexico dimenhydrinate market growth. Adverse effects associated with dimenhydrinate drugs can hinder the growth of the market. Awareness of use as OTC products can create opportunities for boosting the market's demand. The use of novel therapies for treating nausea can challenge the Mexico dimenhydrinate market growth.
The Mexico dimenhydrinate market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief; our team will help you create a revenue impact solution to achieve your desired goal.
Mexico Dimenhydrinate Market Scope and Market Size
The Mexico dimenhydrinate market is categorized into seven segments based on prescription type, application, route of administration, dosage form, product type, age, and distribution channel.
- On the basis of prescription type, the Mexico dimenhydrinate market is segmented into over-the-counter (OTC), and prescription drugs. In 2022, the over-the-counter (OTC) segment is expected to dominate the market since there are no specific laws for the use of OTC medications and the ability to invest in medium-scale companies in Mexico, which manufacture and supply dimenhydrinate. The brands available for our market-focused product in Mexico are OTC drugs.
- On the basis of application, the Mexico dimenhydrinate market is segmented into nausea, vomiting, dizziness, insomnia, allergies, and others. In 2022, the nausea segment is expected to dominate the Mexico dimenhydrinate market due to the rise in the geriatric population in Mexico suffering from motion sickness and increased awareness of treatment of motion sickness.
- On the basis of route of administration, the Mexico dimenhydrinate market is segmented into oral and parenteral. In 2022, the oral segment is expected to dominate the Mexico dimenhydrinate market as most of the drugs offered in the market are oral tablets due to their ease of absorption and availability.
- On the basis of dosage form, the Mexico dimenhydrinate market is segmented into tablets, chewables, syrup, injections, and others. In 2022, the tablets segment is expected to dominate the Mexico dimenhydrinate market since it is widely available and easy to absorb.
- On the basis of product type, the Mexico dimenhydrinate market is segmented into branded and generic. In 2022, the branded segment is expected to dominate the Mexico dimenhydrinate market, as most of the branded drugs offered by the companies are originally submitted by the Food and Drug Administration (FDA) and Federal Commission for the Protection against Sanitary Risk (COFEPRIS) and are highly used by consumers.
- On the basis of age group, the Mexico dimenhydrinate market is segmented into adult, geriatric, and child. In 2022, the adult segment is expected to dominate the Mexico dimenhydrinate market due to a rise in cases of nausea and dizziness cases among adults.
- On the basis of distribution channel, the Mexico dimenhydrinate market is segmented into store based retail and online based retail. In 2022, the store based retail segment is expected to dominate the Mexico dimenhydrinate market due to increased interaction with certified prescribers and health professionals for the use of anti-depressants and guaranteed payment.
Growing strategic activities by major market players to enhance awareness of dimenhydrinate to boost the market growth
The Mexico dimenhydrinate market also provides detailed market analysis for every country's growth in a particular market. Additionally, it provides detailed information regarding the market players' strategy and geographical presence. The data is available for the historical period 2011 to 2020.
Competitive Landscape and Mexico Dimenhydrinate Market Share Analysis
The Mexico dimenhydrinate market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies' focus related to Mexico Dimenhydrinate market
Some of the major players operating in the Mexico dimenhydrinate market are Johnson & Johnson SA de CV, Prestige Consumer Healthcare Inc., and CINFA LABORATORIES (a subsidiary of Mundipharma), among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many contracts and agreements are also initiated by the companies worldwide, which are further accelerating the Mexico dimenhydrinate market growth.
For instance,
- In July 2021, Prestige Consumer Healthcare announced that it had completed the acquisition of TheraTears and other over-the-counter consumer brands. This is expected to increase the company's manufacturing capacity in the U.S. and help in revenue generation.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MEXICO DIMENHYDRINATE MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MEXICO DIMENHYDRINATE MARKET: SEGMENTATION
2.1 MARKETS COVERED
2.2 COUNTRY SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 CAUSE SEGMENT LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 MARKET END USER COVERAGE GRID
2.1 SECONDARY SOURCES
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTERS FIVE FORCES
5 MEXICO DEMENHYDRINATE MARKET: REGULATORY SCENARIO
5.1 KEY REGULATORY INFORMATION
5.2 GOOD MANUFACTURING PRACTICES (GMP) INSPECTION
5.3 TIMELINE TO APPROVE A DRUG
6 SUMMARY WRITE UP (MEXICO)
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING PREVALENCE OF ALLERGIC DISORDER
7.1.2 INCREASE IN VULERABLE GERIATIC POPULATIONS
7.1.3 WIDE RANGE OF PRODUCT PORTFOLIO OFFERED BY MAJOR PLAYER
7.1.4 HEALTH SECTOR REFORM AND EXPANSION OF PROGRAMMES TO BOOST HEALTHCARE SPENDING
7.1.5 IMPACT OF POLLEN ALLERGIES ON PAEDIATRICS POPULATION IN MEXICAN ATMOSPHERE
7.2 RESTRAINTS
7.2.1 SIDE EFFECTS ASSOCIATED WITH THE USE OF DIMENHYDRINATE
7.2.2 AVAILABILITY OF OTHER ANTIHISTAMINES
7.2.3 INCREASE IN TREND OF USING HOME REMEDIES/PHYTOCHEMICALS
7.3 OPPORTUNITIES
7.3.1 AWARENESS FOR USE OF OTC PRODUCTS
7.3.2 RELAXATION OF RULES ON DIRECT-TO-CONSUMER ADVERTISING
7.4 CHALLENGES
7.4.1 INCREASE IN ABUSE POTENTIAL
7.4.2 INTELLECTUAL PROPERTYY RIGHTS LAW
8 MEXICO DIMENHYDRINATE MARKET, BY PRESCRIPTION TYPE
8.1 OVERVIEW
8.2 OVER-THE-COUNTER (OTC)
8.3 PRESCRIPTION DRUGS
9 MEXICO DIMENHYDRINATE MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 NAUSEA
9.2.1 NAUSEA, BY DOSAGE FORM
9.2.1.1 TABLETS
9.2.1.2 CHEWABLES
9.2.1.3 SYRUP
9.2.1.4 INJECTIONS
9.2.1.5 OTHERS
9.3 VOMITING
9.3.1 VOMITING, BY DOSAGE FORM
9.3.1.1 TABLETS
9.3.1.2 CHEWABLES
9.3.1.3 SYRUP
9.3.1.4 INJECTIONS
9.3.1.5 OTHERS
9.4 DIZZINESS
9.4.1 DIZZINES, BY DOSAGE FORM
9.4.1.1 TABLETS
9.4.1.2 CHEWABLES
9.4.1.3 SYRUP
9.4.1.4 INJECTIONS
9.4.1.5 OTHERS
9.5 INSOMNIA
9.5.1 INSOMNIA, BY DOSAGE FORM
9.5.1.1 TABLETS
9.5.1.2 CHEWABLES
9.5.1.3 SYRUP
9.5.1.4 INJECTIONS
9.5.1.5 OTHERS
9.6 ALLERGIES
9.6.1 ALLERGIES, BY DOSAGE FORM
9.6.1.1 TABLETS
9.6.1.2 CHEWABLES
9.6.1.3 SYRUP
9.6.1.4 INJECTIONS
9.6.1.5 OTHERS
9.7 OTHERS
10 MEXICO DIMENHYDRINATE MARKET, BY ROUTE OF ADMINISTRATION
10.1 OVERVIEW
10.2 ORAL
10.2.1 ORAL, BY TYPE
10.2.1.1 SWALLOW TABLETS
10.2.1.2 CHEWABLES
10.2.1.3 OTHERS
10.3 PARENTERAL
11 MEXICO DIMENHYDRINATE MARKET, BY DOSAGE FORM
11.1 OVERVIEW
11.2 TABLETS
11.3 CHEWABLES
11.3.1 CHEWABLES, BY FLAVOR
11.3.1.1 GINGER
11.3.1.2 ORANGE
11.3.1.3 GRAPE FLAVOR
11.3.1.4 OTHERS
11.4 SYRUP
11.5 INJECTIONS
11.6 OTHERS
12 MEXICO DIMENHYDRINATE MARKET, BY PRODUCT TYPE
12.1 OVERVIEW
12.2 BRANDED
12.3 GENERIC
13 MEXICO DIMENHYDRINATE MARKET, BY AGE
13.1 OVERVIEW
13.2 ADULT
13.3 GERIATRIC
13.4 CHILD
14 MEXICO DIMENHYDRINATE MARKET, BY DISTRIBUTION CHANNEL
14.1 OVERVIEW
14.2 STORE BASED RETAIL
14.2.1 PHARMACIES AND DRUG STORES
14.2.2 SUPERMARKET/HYPERMARKET
14.2.3 HOSPITAL PHARMACIES
14.2.4 CONVENIENCE STORE
14.2.5 SPECIALITY STORES
14.2.6 OTHERS
14.3 ONLINE BASED RETAIL
15 MEXICO DIMENHYDRINATE MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: MEXICO
16 SWOT ANALYSIS
17 COMPANY PROFILES
17.1 JOHNSON & JOHNSON SA DE CV
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 PRODUCT PORTFOLIO
17.1.4 RECENT DEVELOPMENT
17.2 PRESTIGE CONSUMER HEALTHCARE INC.
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 PRODUCT PORTFOLIO
17.2.4 RECENT DEVELOPMENT
17.2.4.1 ACQUISITION
17.3 CINFA LABORATORIES (SUBSIDIARY OF MUNDIPHARMA)
17.3.1 COMPANY SNAPSHOT
17.3.2 PRODUCT PORTFOLIO
17.3.3 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
List of Table
TABLE 1 MEXICO DIMENHYDRINATE MARKET, BY PRESCRIPTION TYPE, 2020-2029 (USD THOUSAND)
TABLE 2 MEXICO DIMENHYDRINATE MARKET, BY APPLICATION , 2020-2029 (USD THOUSAND)
TABLE 3 MEXICO NAUSEA IN DIMENHYDRINATE MARKET, BY DOSAGE FORM, 2020-2029 (USD THOUSAND)
TABLE 4 MEXICO VOMITING IN DIMENHYDRINATE MARKET, BY DOSAGE FORM, 2020-2029 (USD THOUSAND)
TABLE 5 MEXICO DIZZINESS IN DIMENHYDRINATE MARKET, BY DOSAGE FORM, 2020-2029 (USD THOUSAND)
TABLE 6 MEXICO INSOMNIA IN DIMENHYDRINATE MARKET, BY DOSAGE FORM, 2020-2029 (USD THOUSAND)
TABLE 7 MEXICO ALLERGIES IN DIMENHYDRINATE MARKET, BY DOSAGE FORM, 2020-2029 (USD THOUSAND)
TABLE 8 MEXICO DIMENHYDRINATE MARKET, BY ROUTE OF ADMINISTRATION, 2020-2029 (USD THOUSAND)
TABLE 9 MEXICO ORAL IN DIMENHYDRINATE MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 10 MEXICO DIMENHYDRINATE MARKET, BY DOSAGE FORM , 2020-2029 (USD THOUSAND)
TABLE 11 MEXICO CHEWABLES IN DIMENHYDRINATE MARKET, BY FLAVOR, 2020-2029 (USD THOUSAND)
TABLE 12 MEXICO DIMENHYDRINATE MARKET, BY PRODUCT TYPE , 2020-2029 (USD THOUSAND)
TABLE 13 MEXICO DIMENHYDRINATE MARKET, BY AGE, 2020-2029 (USD THOUSAND)
TABLE 14 MEXICO DIMENHYDRINATE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
TABLE 15 MEXICO STORE BASED RETAIL IN DIMENHYDRINATE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
List of Figure
FIGURE 1 MEXICO DIMENHYDRINATE MARKET: SEGMENTATION
FIGURE 2 MEXICO DIMENHYDRINATE MARKET: DATA TRIANGULATION
FIGURE 3 MEXICO DIMENHYDRINATE MARKET: DROC ANALYSIS
FIGURE 4 MEXICO DIMENHYDRINATE MARKET: REGIONAL VS COUNTRY ANALYSIS
FIGURE 5 MEXICO DIMENHYDRINATE MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MEXICO DIMENHYDRINATE MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MEXICO DIMENHYDRINATE MARKET: DBMR POSITION GRID
FIGURE 8 MEXICO DIMENHYDRINATE MARKET: END USER COVERAGE GRID
FIGURE 9 MEXICO DIMENHYDRINATE MARKET: SEGMENTATION
FIGURE 10 THE SURGE IN INCIDENCE CASES OF ALLERGIES, NAUSEA AND DIZZINESS AND RISE IN PRODUCT APPPROVALS IS EXPECTED TO DRIVE THE MEXICO DIMENHYDRINATE MARKET FROM 2022 TO 2029
FIGURE 11 PRESCRIPTION TYPE SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE MEXICO DIMENHYDRINATE MARKET FROM 2022 & 2029
FIGURE 12 DRIVERS, RESTRIANTS, OPPORTUNITIES, AND CHALLENGES OF MEXICO DIMENHYDRINATE MARKET
FIGURE 13 MEXICO DIMENHYDRINATE MARKET: BY PRESCRIPTION TYPE, 2021
FIGURE 14 MEXICO DIMENHYDRINATE MARKET: BY PRESCRIPTION TYPE, 2020-2029 (USD THOUSAND)
FIGURE 15 MEXICO DIMENHYDRINATE MARKET: BY PRESCRIPTION TYPE, CAGR (2022-2029)
FIGURE 16 MEXICO DIMENHYDRINATE MARKET: BY PRESCRIPTION TYPE, LIFELINE CURVE
FIGURE 17 MEXICO DIMENHYDRINATE MARKET: BY APPLICATION, 2021
FIGURE 18 MEXICO DIMENHYDRINATE MARKET: BY APPLICATION, 2020-2029 (USD THOUSAND)
FIGURE 19 MEXICO DIMENHYDRINATE MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 20 MEXICO DIMENHYDRINATE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 21 MEXICO DIMENHYDRINATE MARKET: BY ROUTE OF ADMINISTRATION, 2021
FIGURE 22 MEXICO DIMENHYDRINATE MARKET: BY ROUTE OF ADMINISTRATION, 2020-2029 (USD THOUSAND)
FIGURE 23 MEXICO DIMENHYDRINATE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2022-2029)
FIGURE 24 MEXICO DIMENHYDRINATE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 25 MEXICO DIMENHYDRINATE MARKET: BY DOSAGE FORM, 2021
FIGURE 26 MEXICO DIMENHYDRINATE MARKET: BY DOSAGE FORM, 2020-2029 (USD THOUSAND)
FIGURE 27 MEXICO DIMENHYDRINATE MARKET: BY DOSAGE FORM, CAGR (2022-2029)
FIGURE 28 MEXICO DIMENHYDRINATE MARKET: BY DOSAGE FORM, LIFELINE CURVE
FIGURE 29 MEXICO DIMENHYDRINATE MARKET: BY PRODUCT TYPE, 2021
FIGURE 30 MEXICO DIMENHYDRINATE MARKET: BY PRODUCT TYPE, 2020-2029 (USD THOUSAND)
FIGURE 31 MEXICO DIMENHYDRINATE MARKET: BY PRODUCT TYPE, CAGR (2022-2029)
FIGURE 32 MEXICO DIMENHYDRINATE MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 33 MEXICO DIMENHYDRINATE MARKET: BY AGE, 2021
FIGURE 34 MEXICO DIMENHYDRINATE MARKET: BY AGE, 2020-2029 (USD THOUSAND)
FIGURE 35 MEXICO DIMENHYDRINATE MARKET: BY AGE, CAGR (2022-2029)
FIGURE 36 MEXICO DIMENHYDRINATE MARKET: BY AGE, LIFELINE CURVE
FIGURE 37 MEXICO DIMENHYDRINATE MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 38 MEXICO DIMENHYDRINATE MARKET: BY DISTRIBUTION CHANNEL, 2020-2029 (USD THOUSAND)
FIGURE 39 MEXICO DIMENHYDRINATE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 40 MEXICO DIMENHYDRINATE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 41 MEXICO DIMENHYDRINATE MARKET: COMPANY SHARE 2021 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
